Silverarc Capital Management’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Silverarc Capital Management’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-192,995	Closed	-$1.41M	–	107
2022 Q4	$1.41M	Buy	192,995 +4,695	+2%	+$33.1K	0.4%	62
2022 Q3	$1.3M	Buy	188,300 +11,991	+7%	+$89.5K	0.44%	56
2022 Q2	$1.23M	Buy	176,309 +23,042	+15%	+$180K	0.38%	50
2022 Q1	$1.27M	Sell	153,267 -196,946	-56%	-$1.78M	0.52%	48
2021 Q4	$3.78M	Sell	350,213 -166,008	-32%	-$1.79M	1.53%	20
2021 Q3	$6.22M	Buy	516,221 +59,684	+13%	+$674K	3.52%	5
2021 Q2	$5.54M	Buy	456,537 +26,674	+6%	+$331K	2.47%	8
2021 Q1	$5.99M	Buy	429,863 +27,307	+7%	+$382K	3.27%	5
2020 Q4	$5.7M	Buy	+402,556	New	+$5.25M	3.31%	6

Other funds holding AMYT

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Silverarc Capital Management's AMYT Position: Q1 2023 in Review

Silverarc Capital Management sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 192,995 shares — an estimated $1.41M sold.

Silverarc Capital Management first reported a position in AMYT in Q4 2020 and held it in 9 quarters. The position peaked at $6.22M in Q3 2021. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

Silverarc Capital Management reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Silverarc Capital Management sold 192,995 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $1.41M.
Silverarc Capital Management first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2020 and held it in 9 quarters.
Silverarc Capital Management's Amryt Pharma plc American Depositary Shares position peaked at $6.22M in Q3 2021.
79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on Silverarc Capital Management's 13F filing for Q1 2023, filed 15 May 2023.